HOME Top Market Reports Tumor Ablation Market by Technology (Radiofrequency, Microwave, Cryoablation, IRE, Ultrasound, Laser), Mode of Treatment (Surgical, Laparoscopic, Percutaneous), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecast 2021

Tumor Ablation Market by Technology (Radiofrequency, Microwave, Cryoablation, IRE, Ultrasound, Laser), Mode of Treatment (Surgical, Laparoscopic, Percutaneous), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecast 2021

By: marketsandmarkets.com
Publishing Date: October 2016
Report Code: MD 3271

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global tumor ablation market is estimated to reach USD 580.1 Million by 2021, at a CAGR of 12.5% during the forecast period. A number of factors such as technological advancements in the field of tumor ablation focused on enhancing effectiveness and safety of the treatment, rising demand of minimal invasive tumor ablation techniques, increasing prevalence of cancer across the globe, and growing public-private initiatives and funding to support R&D activities in tumor ablation are propelling the growth of the market. However, factors such as unfavorable regulatory policies and cost-containment measures adopted by various governments are restraining the optimal market growth.

Emerging markets (such as China and India) are offering high growth opportunities for market players operating in the tumor ablation industry. Increasing prevalence of cancer along with rising elderly population and growing medical tourism across major Asian countries are driving the demand for tumor ablation products in emerging nations. In order to leverage growth opportunities in these emerging nations, leading market players are expanding their presence in these countries.

As of 2016, Medtronic plc (Ireland) held the leadership position in the global tumor ablation market. Over the past three years, the company has adopted new product launches, product enhancements, and geographic expansion as its key business strategies to ensure market dominance. Angiodynamics, Inc. (U.S.), Boston Scientific Corporation (U.S.), Galil Medical, Inc. (U.S.), EDAP TMS S.A. (France), Healthtronics, Inc. (U.S.), Medtronic, Plc (U.S.), Mermaid Medical, Inc. (Denmark), Mesonix, Inc. (U.S.), Neuwave Medical, Inc. (U.S.), and Sonacare Medical, LLC (U.S.) are some of the other key players operating in the market.

Target Audience

  • Tumor ablation device manufacturers
  • Government and independent associations and organizations
  • Healthcare service providers (such as hospitals, outpatient clinics, surgical, and ablation centers)
  • Distributors, suppliers, and commercial service providers
  • Contract manufacturing organizations (CMOs)
  • Clinical research organizations (CROs)
  • Research laboratories and academic institutes
  • Market research and consulting firms

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This research report categorizes the market into the following segments:

Tumor Ablation Market, by Technology

  • Radiofrequency (RF) Ablation
  • Microwave Ablation
  • Cryoablation
  • Other Technologies

Tumor Ablation Market, by Mode of Treatment

  • Percutaneous Ablation
  • Laparoscopic Ablation
  • Surgical Ablation

Tumor Ablation Market, by Application

  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Bone Metastasis
  • Others

Tumor Ablation Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Italy
    • Germany
    • France
    • U.K.
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for tumor ablation market report:

Product Analysis

  • Product Matrix which gives a detailed comparison of the product portfolios of each company

Geographical Analysis

  • Further breakdown of the RoAPAC market into the Australia, Rest of Pacific, and Rest of Asia
  • Further breakdown of the RoW market into the Middle East, Latin America, and Africa

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Geographic Scope
           1.3.3 Years Considered for the Study
    1.4 Limitations
    1.5 Market Stakeholders

2 Research Methodology
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
                    2.1.2.3 Breakdown of Primaries
    2.2 Market Size Estimation
           2.2.1 Top-Down Approach
           2.2.2 Bottom-Up Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions

3 Executive Summary
    3.1 Introduction
    3.2 History, Evolution, and Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 Market, By Technology
           5.2.2 Market, By Mode of Treatment
           5.3.3 Market, By Application
    5.3 Market Evolution
    5.4 Market Dynamics 
           5.4.1 Key Market Drivers
                    5.4.1.1 Growing Geriatric Population Across the World
                    5.4.1.2 Increasing Population Base for Cancer Patients
                    5.4.1.3 Technological Advancements in Ablation Devices
                    5.4.1.4 Sprouting Number of Hospitals, Surgical, and Ablation Centers
           5.4.2 Key Market Restraints
                    5.4.2.1 Cost Containment Measures Taken By Various Governments
                    5.4.2.2 Ongoing Healthcare Reforms in the U.S.
           5.4.3 Key Market Opportunities
                    5.4.3.1 Growth Potential Offered By Emerging Markets
                    5.4.3.2 Growing Awareness About Ablation Procedures Over Conventional Therapeutic and Surgical Procedures
           5.4.4 Key Market Challenges
                    5.4.4.1 Stringent Regulatory Guidelines Leading to Significant Increase in Gestation Period of Product Launches

6 Industry Insights
    6.1 Introduction
    6.2 Value Chain Analysis
    6.3 Industry Trends
           6.3.1 Growing Adoption Rate of Radiofrequency-Based Tumor Ablation Procedures
           6.3.2 Microwave Technology to Be the Fastest Growing Segment in Overall Tumor Ablation Businesses
    6.4 Porter's Five Forces Analysis
           6.4.1 Threat From New Entrants
           6.4.2 Threat From Substitutes
           6.4.3 Bargaining Power of Suppliers
           6.4.4 Bargaining Power of Buyers
           6.4.5 Intensity of Competitive Rivalry

7 Tumor Ablation Market, By Technology
    7.1 Introduction
    7.2 Radiofrequency (RF) Ablation 
    7.3 Microwave Ablation
    7.4 Cryoablation 
    7.5 Other Technologies*

8 Tumor Ablation Market, By Mode of Treatment
    8.1 Introduction
    8.2 Surgical Ablation
    8.3 Laparoscopic Ablation 
    8.4 Percutaneous Ablation

9 Tumor Ablation Market, By Application
    9.1 Introduction
    9.2 Liver Cancer
    9.3 Lung Cancer
    9.4 Kidney Cancer
    9.5 Bone Metastasis
    9.6 Others**

10 Tumor Ablation Market, By Region
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Italy
             10.3.2 Germany
             10.3.3 France
             10.3.4 U.K.
             10.3.5 Spain
             10.3.6 Rest of Europe
     10.4 Asia-Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia-Pacific
     10.5 Rest of the World (RoW)

11 Competitive Landscape
     11.1 Introduction
     11.2 Market Share Analysis, By Key Players
     11.3 Competitive Scenario
     11.4 Recent Developments
             11.4.1 New Products Launches and Product Enhancements
             11.4.2 Agreements, Partnerships, and Agreements
             11.4.3 Mergers and Acquisitions
             11.4.4 Geographic Expansions
             11.4.5 Other Developments

12 Compny Profiles
     12.1 Introduction
             12.1.1 Geographic Benchmarking
             12.1.2 Strategic Benchmarking
     12.2 Medtronic, PLC.
             12.2.1 Company Overview
             12.2.2 MnM Overview
             12.2.3 Medtronic, PLC: Company Snapshot
             12.2.4 Product Portfolio
             12.2.5 Recent Developments (2014-2015)
     12.3 Angiodynamics, Inc.
             12.3.1 Company Overview
             12.3.2 MnM Overview
             12.3.3 Angiodynamics, Inc.: Company Snapshot
             12.3.4 Product Portfolio
             12.3.5 Recent Developments (2014-2015)
     12.4 Healthtronics, Inc.
             12.4.1 Company Overview
             12.4.2 MnM Overview
             12.4.3 Boston Scientific Corporation: Company Snapshot
             12.4.4 Product Portfolio
             12.4.5 Recent Developments (2014-2015)
     12.5 Galil Medical, Inc.
             12.5.1 Company Overview
             12.5.2 MnM Overview
             12.5.3 Endo International PLC: Company Snapshot
             12.5.4 Product Portfolio
             12.5.5 Recent Developments (2014-2015)
     12.6 Boston Scientific Corporation 
             12.6.1 Company Overview
             12.6.2 MnM Overview
             12.6.3 Product Portfolio
             12.6.4 Recent Developments (2014-2015)
     12.7 Neuwave Medical, Inc.
             12.7.1 Company Overview
             12.7.3 Edap Tms S.A.: Company Snapshot
             12.7.4 Product Portfolio
             12.7.5 Recent Developments (2014-2015)
     12.8 Edap Tms S.A.
             12.8.1 Company Overview
             12.8.2 Product Portfolio
             12.8.3 Recent Developments (2014-2015)
     12.9 Mermaid Medical A/S 
             12.9.1 Company Overview
             12.9.2 Product Portfolio
             12.9.3 Recent Developments (2014-2015)
     12.10 Sonacare Medical, LLC 
             12.10.1 Company Overview
             12.10.2 Misonix, Inc.: Company Snapshot
             12.10.3 Product Portfolio
             12.10.4 Recent Developments (2014-2015)
     12.11 Misonix, Inc.
             12.11.1 Company Overview
             12.11.2 Product Portfolio
             12.11.3 Recent Developments (2014-2015)

13 Appendix
     13.1 Insights From Industry Experts
     13.2 Discussion Guide
     13.3 Introducing RT: Real Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports


List of Tables (72 Tables)

Table 1 Global Tumor Ablation Market Size, By Technology, 2014-2021 (USD Million)
Table 2 Market Size for Radiofrequency Ablation Technologies, By Region, 2014-2021 (USD Million)
Table 3 Market Size for Microwave Ablation Technology, By Region, 2014-2021 (USD Million)
Table 4 Market Size for Cryoablation Technology, By Region, 2014-2021 (USD Million)
Table 5 Market Size for Other Technologies, By Region, 2014-2021 (USD Million)
Table 6 Global Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 7 Market Size for Surgical Ablation Treatment, By Region, 2014-2021 (USD Million)
Table 8 Market Size for Laparoscopic Ablation Treatment, By Region, 2014-2021 (USD Million)
Table 9 Market Size for Percutaneous Ablation Treatment, By Region, 2014-2021 (USD Million)
Table 10 Global Market Size, By Application, 2014-2021 (USD Million)
Table 11 Market Size for Liver Cancer Ablation, By Region, 2014-2021 (USD Million)
Table 12 Market Size for Lung Cancer Ablation, By Region, 2014-2021 (USD Million)
Table 13 Market Size for Kidney Cancer Ablation, By Region, 2014-2021 (USD Million)
Table 14 Market Size for Bone Metastasis Ablation, By Region, 2014-2021 (USD Million)
Table 15 Market Size for Other Applications, By Region, 2014-2021 (USD Million)
Table 16 Market Size, By Region, 2014-2021 (USD Million)
Table 17 North American Market Size, By Country, 2014-2021 (USD Million)
Table 18 North American Market Size, By Technology, 2014-2021 (USD Million)
Table 19 North American Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 20 North American Market Size, By Application, 2014-2021 (USD Million)
Table 21 U.S.: Market Size, By Technology, 2014-2021 (USD Million)
Table 22 U.S.: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 23 U.S.: Market Size, By Application, 2014-2021 (USD Million)
Table 24 Canada: Market Size, By Technology, 2014-2021 (USD Million)
Table 25 Canada: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 26 Canada: Market Size, By Application, 2014-2021 (USD Million)
Table 27 European Market Size, By Country, 2014-2021 (USD Million)
Table 28 European Market Size, By Technology, 2014-2021 (USD Million)
Table 29 European Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 30 European Market Size, By Application, 2014-2021 (USD Million)
Table 31 Italy: Market Size, By Technology, 2014-2021 (USD Million)
Table 32 Italy: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 33 Italy: Market Size, By Application, 2014-2021 (USD Million)
Table 34 Germany: Market Size, By Technology, 2014-2021 (USD Million)
Table 35 Germany: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 36 Germany: Market Size, By Application, 2014-2021 (USD Million)
Table 37 France: Market Size, By Technology, 2014-2021 (USD Million)
Table 38 France: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 39 France: Market Size, By Application, 2014-2021 (USD Million)
Table 40 U.K.: Market Size, By Technology, 2014-2021 (USD Million)
Table 41 U.K.: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 42 U.K.: Market Size, By Application, 2014-2021 (USD Million)
Table 43 Spain: Market Size, By Technology, 2014-2021 (USD Million)
Table 44 Spain: Market Size, By Mode of Treatment, 2014-2021 (USD Million
Table 45 Spain: Market Size, By Application, 2014-2021 (USD Million)
Table 46 Rest of Europe: Market Size, By Technology, 2014-2021 (USD Million)
Table 47 Rest of Europe: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 48 Rest of Europe: Market Size, By Application, 2014-2021 (USD Million)
Table 49 Asia-Pacific Market Size, By Country, 2014-2021 (USD Million)
Table 50 Asia-Pacific Market Size, By Technology, 2014-2021 (USD Million)
Table 51 Asia-Pacific Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 52 Asia-Pacific Market Size, By Application, 2014-2021 (USD Million)
Table 53 Japan: Market Size, By Technology, 2014-2021 (USD Million)
Table 54 Japan: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 55 Japan: Market Size, By Application, 2014-2021 (USD Million)
Table 56 China: Market Size, By Technology, 2014-2021 (USD Million)
Table 57 China: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 58 China: Market Size, By Application, 2014-2021 (USD Million)
Table 59 India: Market Size, By Technology, 2014-2021 (USD Million)
Table 60 India: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 61 India: Market Size, By Application, 2014-2021 (USD Million)
Table 62 Rest of Asia-Pacific: Market Size, By Technology, 2014-2021 (USD Million)
Table 63 Rest of Asia-Pacific: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 64 Rest of Asia-Pacific: Market Size, By Application, 2014-2021 (USD Million)
Table 65 RoW: Market Size, By Technology, 2014-2021 (USD Million)
Table 66 RoW: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 67 RoW: Market Size, By Application, 2014-2021 (USD Million)
Table 68 Top 5 New Product Launches and Product Enhancements, 2013–2016
Table 69 Top 5 Agreements, Partnerships, and Collaborations, 2013–2016
Table 70 Top 5 Geographical Expansions, 2013–2016
Table 71 Top 5 Mergers and Acquisitions, 2013–2016
Table 72 Top 5 Other Developments, 2013–2016


List of Figures (86 Figures)

Figure 1 Research Design
Figure 2 Data Triangulation
Figure 3 North America to Hold Largest Share of  Market During the Forecast Period
Figure 4 RF Ablation to Lead the Revenue Growth of Tumor Ablation Technology Market During 2016-2021
Figure 5 Microwave Ablation Technology to Grow at Fastest CAGR During Study Period
Figure 6 North America to Dominate Surgical Tumor Ablation Treatment Market Till 2021
Figure 7 Liver Cancer to Lead Tumor Ablation Application Market During Forecast Period
Figure 8 Rise in Target Patient Population to Propel the Market Growth of Liver Cancer Ablation in APAC
Figure 9 Increasing Geriatric Population Across Key Mature and Emerging Nations
Figure 10 Worldwide Prevalence of Cancer – Expected Trend Till 2020
Figure 11 Market, By Technology: Expected Trend During 2016-2021
Figure 12 Market Share: RF Ablation Technology Market, By Region (2016)
Figure 13 Market Share: Microwave Ablation Technology Market, By Region (2016)
Figure 14 Market Share: Cryoablation Technology Market, By Region (2065)
Figure 15 Market Share: Other Ablation Technologies Market, By Region (2016)
Figure 16 Market, By Mode of Treatment: Expected Trend During 2016-2021
Figure 17 Market Share: Surgical Ablation Treatment Market, By Region (2016)
Figure 18 Market Share: Laparoscopic Ablation Treatment Market, By Region (2016)
Figure 19 Market Share: Percutaneous Ablation Treatment Market, By Region (2016)
Figure 20 Market, By Application: Expected Trend During 2016-2021
Figure 21 Market Share: Liver Cancer Ablation Market, By Region (2016)
Figure 22 Market Share: Lung Cancer Ablation Market, By Region (2016)
Figure 23 Market Share: Kidney Cancer Ablation Market, By Region (2016)
Figure 24 Market Share: Bone Metastasis Ablation Market, By Region (2016)
Figure 25 Market Share: Other Applications Market, By Region (2016)
Figure 26 Key Market Drivers for Global Market (2016-2021)
Figure 27 North America: Market, Expected Trend (2016 vs 2021)
Figure 28 North America: Market Share, By Technology, 2016
Figure 29 U.S.: Key Market Drivers for Market (2016-2021)
Figure 30 U.S.: Market Share, By Technology (2016)
Figure 31 U.S.: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 32 U.S.: Tumor Ablation Market Share, By Application (2016)
Figure 33 Canada: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 34 Canada: Tumor Ablation Market Share, By Technology (2016)
Figure 35 Canada: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 36 Canada: Tumor Ablation Market Share, By Application (2016)
Figure 37 Europe: Tumor Ablation Market, Expected Trend (2016 vs 2021)
Figure 38 Eu-5: Tumor Ablation Market Share, By Technology, 2016
Figure 39 Italy: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 40 Italy: Tumor Ablation Market Share, By Technology (2016)
Figure 41 Italy: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 42 Italy: Tumor Ablation Market Share, By Application (2016)
Figure 43 Germany: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 44 Germany: Tumor Ablation Market Share, By Technology (2016)
Figure 45 Germany: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 46 Germany: Tumor Ablation Market Share, By Application (2016)
Figure 47 France: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 48 France: Tumor Ablation Market Share, By Technology (2016)
Figure 49 France: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 50 France: Tumor Ablation Market Share, By Application (2016)
Figure 51 U.K.: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 52 U.K.: Tumor Ablation Market Share, By Technology (2016)
Figure 53 U.K.: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 54 U.K.: Tumor Ablation Market Share, By Application (2016)
Figure 55 Spain: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 56 Spain: Tumor Ablation Market Share, By Technology (2016)
Figure 57 Spain: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 58 Spain: Tumor Ablation Market Share, By Application (2016)
Figure 59 RoE: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 60 RoE: Tumor Ablation Market Share, By Technology (2016)
Figure 61 RoE: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 62 RoE: Tumor Ablation Market Share, By Application (2016)
Figure 63 Asia-Pacific: Tumor Ablation Market, Expected Trend (2016 vs 2021)
Figure 64 Asia-Pacific: Tumor Ablation Market Share, By Technology, 2016
Figure 65 Japan: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 66 Japan: Tumor Ablation Market Share, By Technology (2016)
Figure 67 Japan: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 68 Japan: Tumor Ablation Market Share, By Application (2016)
Figure 69 China: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 70 China: Tumor Ablation Market Share, By Technology (2016)
Figure 71 China: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 72 China: Tumor Ablation Market Share, By Application (2016)
Figure 73 India: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 74 India: Tumor Ablation Market Share, By Technology (2016)
Figure 75 India: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 76 India: Tumor Ablation Market Share, By Application (2016)
Figure 77 RoAPAC: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 78 RoAPAC: Tumor Ablation Market Share, By Technology (2016)
Figure 79 RoAPAC: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 80 RoAPAC: Tumor Ablation Market Share, By Application (2016)
Figure 81 RoW: Tumor Ablation Market, Expected Trend (2016 vs 2021)
Figure 82 RoW: Tumor Ablation Market Share, By Technology, 2016
Figure 83 Market Share Analysis: Medtronic, PLC to Lead Tumor Ablation Market Till 2021
Figure 84 Majority of Leading Players Focused on Product Development as Key Growth Strategy to Expand Their Market Share During Study Period
Figure 85 Top 4 Players Generated More Than 3/5th of Their Tumor Ablation Revenue From Americas
Figure 86 Technological Development and Product Enhancement is the Key Strategy Pursued By Top Players to Increase Their Tumor Ablation Market Revenue

The global tumor ablation market is expected to reach a value of USD 580.1 Million by 2021, at a CAGR of 12.5% during 2016-2021. A number of factors such as technological advancements in the field of tumor ablation focused on enhancing effectiveness and safety of the treatment, rising demand of minimal invasive tumor ablation techniques, increasing prevalence of cancer across the globe, and growing public-private initiatives and funding to support R&D activities in tumor ablation are propelling the growth of the market. However, factors such as unfavorable regulatory policies and cost-containment measures adopted by various governments are restraining the optimal market growth.

On the basis of technology, the global tumor ablation market is divided into four major categories, namely, radiofrequency ablation, microwave ablation, cryoablation, and others (includes electrical, laser/light, ultrasound). Based on mode of treatment, the market is segmented into surgical mode, laparoscopic mode, and percutaneous mode. On the basis of application of tumor ablation, the market is categorized into liver cancer, lung cancer, kidney/renal cancer, bone metastasis, and others (includes tumor ablation for the treatment of prostate, breast, colorectal, thyroid, pancreas, neuroendocrine, head, neck, and lumbar-vertebra cancer). In 2016, the radiofrequency ablation technology is estimated to dominate the market due its high demand for tumor ablation. The microwave ablation technology is estimated to register high growth due to its additional therapeutic benefits such as faster heat-generation (which reduces the susceptibility to damage to surrounding organs and gives opportunity to ablate larger tumors), lower heat-sink effect (that results in destruction of surrounding healthy tissue), and better safety & efficacy profile.

On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is estimated to dominate the global tumor ablation market. The rising prevalence and incidence of major types of cancer (such as liver, lung, kidney, and bone metastasis), rising inclination of patients towards minimally invasive procedures for cancer treatment, and increasing government funding for cancer research are driving the growth of the market in North America. The Asia-Pacific market is expected to register the highest CAGR from 2016 to 2021. This is primarily due to the rising prevalence of various cancers coupled with growing geriatric population, rising market demand of minimally invasive surgical procedures, growing medical tourism, and ongoing initiatives by various governments for the modernization of healthcare infrastructure in the region.

Tumor Ablation Market

New product launches and product enhancements are the key growth strategies adopted by major players to enhance their positions in the global tumor ablation market. Additionally, strategic acquisitions along with geographic expansions; and partnerships, agreements, and collaborations were also adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence in the global market.

As of 2015, Angiodynamics, Inc. (U.S.), Boston Scientific Corporation (U.S.), Galil Medical, Inc. (U.S.), EDAP TMS S.A. (France), Healthtronics, Inc. (U.S.), Medtronic, Plc (U.S.), Mermaid Medical, Inc. (Denmark), Mesonix, Inc. (U.S.), Neuwave Medical, Inc. (U.S.) and Sonacare Medical, LLC (U.S.) were key players operating in the global market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Available Customizations Title

Client Consult Problem Statement :

MnM’s client wanted to explore the opportunities available for their products in the European region. The client was looking for the information related to the potential hospital departments, most adopted technologies, and prevalent indications in EU-5 countries from the perspective of market development.

The client was also interested in the estimation of cancer ablation market by technology (radiofrequency, microwave, cryo, and others), by department (interventional radiology, surgery, and oncology), and by application (liver, lung, kidney, bone, and others)

Solution Provided:
  1. Methodology Adopted by MnM : MnM conducted qualitative & quantitative study with a con....
  1. Methodology Adopted by MnM : MnM conducted qualitative & quantitative study with a constructed sample of oncologists, radiologists, and interventional radiologists from demand-side of this market. Additionally, interviews with industry experts were also conducted to understand market trends and dynamics. At every level the estimates were verified with industry experts (both from demand and supply side) and finally by MarketsandMarkets domain experts. Both, top-down and bottom-up approaches were used to use to derive at an unbiased data. MnM analyzed current & forecast quantitative market information, and developed deep-dive qualitative insights into industry trends & dynamics across each of the target countries.
  2. Actual Solution Provided:
  • Identified key potential departments and respective authorized personnel (involved in purchasing ablation devices) for the client
  • Estimation of total number of ablation procedures in EU-5 countries – Germany, France, U.K., Italy, and Spain
  • Market share analysis of major competitors at country level
  • Competitive landscape of companies
  • Detailed analysis of need-gap incurred in this market
  • Identified end-customer for the client
  • Strategic recommendation for market positioning

Value Delivered:

The client could get an idea about the major departments performing ablation procedures and can target these departments. The study also aided the client in understanding its competitors and help in taking necessary steps to customize its product offerings.

less...
Request Customization
 more...
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Minimally Invasive/Non-Invasive Surgery Markets on KnowledgeStore
Request Demo